Welcome to our dedicated page for Investview SEC filings (Ticker: INVU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Investview, Inc. (INVU), a Nevada-based diversified financial technology company. Through these documents, investors can review how the company reports its financial education and technology operations, blockchain and Bitcoin mining activities, health and wellness manufacturing, and brokerage development efforts.
Annual Reports (Form 10-K) typically present a consolidated view of Investview’s business model, segment structure, and risk factors. For Investview, these filings describe its Financial Education and Technology business (iGenius), Blockchain Technology and Crypto Mining Products and Services segment (SAFETek), Manufacturing and Development of Health, Beauty and Wellness Products segment (Renu Labs and myLife Wellness), and its plans to create a Brokerage and Financial Markets business using the Prodigio trading engine and Opencash Securities LLC.
Quarterly Reports (Form 10-Q) offer interim updates on net revenue, operating results, cash flows, and balance sheet metrics, along with narrative discussion of segment performance. These filings detail how trends in direct selling, Bitcoin network conditions, and wellness manufacturing initiatives affect Investview’s results.
Current Reports (Form 8-K) disclose material events. For example, a Form 8-K filed in January 2026 describes a decision by the Polish Office of Competition and Consumer Protection (UOKiK) concerning iGenius operations in Poland, including an administrative fine and cease-and-desist order subject to appeal. Other 8-Ks may address acquisitions, share repurchase programs, or settlements such as the SEC inquiry into the historical Apex Program.
Ownership and insider activity filings, such as Forms 3, 4, and 5, when available, can be used to track changes in beneficial ownership by Investview’s officers, directors, and significant shareholders.
On Stock Titan, these SEC filings are updated in near real time from EDGAR and paired with AI-powered summaries to help readers quickly understand complex disclosures. The AI tools highlight key points in lengthy 10-K and 10-Q reports, explain the implications of 8-K events, and make it easier to follow how regulatory, operational, and strategic developments affect Investview’s diversified FinTech and wellness operations.
Investview, Inc. appointed Robert Verdun to its Board of Directors effective January 28, 2026. Verdun is a seasoned entrepreneur and corporate director with leadership roles at Scaling Up Network LLC, Solyco Capital, United Wholesale Mortgage, and Medwatch Technologies.
He was designated to the Board by Chairman David B. Rothrock under existing voting agreement rights. In connection with his appointment, Verdun received a stock option for 25,000,000 shares of common stock at an exercise price of $0.05, granted under the 2022 Incentive Plan. The option vests in five equal tranches of 5,000,000 shares on February 5 of each year from 2027 through 2031, conditioned on his continued service with the company.
Verdun will also receive customary non‑employee director compensation consistent with the company’s other non‑employee director. The company announced his election in a February 3, 2026 press release attached as an exhibit.
Investview director Robert Verdun was granted stock options for 25,000,000 shares of common stock on January 28, 2026 at an exercise price of $0.05 per share. These options are direct holdings.
According to the vesting schedule, 5,000,000 shares vest on each of February 5, 2027, 2028, 2029, 2030, and 2031. After this grant, Verdun directly owns 1,050,000 shares of Investview common stock, separate from the option position.
Investview, Inc. director Robert Verdun filed an initial ownership report showing his stake in the company. The filing states that he beneficially owns 1,050,000 shares of Investview common stock, held directly in his name. There are no derivative securities reported in this Form 3.
Investview, Inc. reported that the Polish Office of Competition and Consumer Protection (UOKiK) has issued an administrative decision against its iGenius unit in Poland. UOKiK found that aspects of the iGenius business model violate Polish laws on unfair commercial practices, including rules prohibiting pyramid-style promotional schemes, and imposed a fine of PLN 14,668,589 (approximately USD $4 million) plus a cease-and-desist order.
Investview disagrees with the decision based on its interpretation of Polish law and plans to use all available appeal rights before a Polish court, during which it expects to continue operating in Poland while evaluating potential business adjustments. The company warns that an unsuccessful appeal could lead to payment of the fine and require modification, suspension, or discontinuation of a material portion of its Polish iGenius operations, and that similar actions by other regulators in Europe or the United States could materially adversely affect its business, financial condition, results of operations, or prospects.
Investview, Inc. reported lower sales and a small loss for the quarter ended September 30, 2025. Quarterly revenue was $9,052,608, down from the prior year’s comparable period, and the company recorded a net loss of $854,143. For the first nine months of 2025, revenue totaled $29,106,578 with a net loss of $1,114,512, compared with a profit in the prior year.
Cash and cash equivalents were $15,080,456 as of September 30, 2025, versus $22,467,710 at December 31, 2024, reflecting operating cash outflows. Total liabilities declined to $10,840,128 from $14,372,010, while stockholders’ equity was $16,648,582. The company adopted new crypto accounting (ASU 2023-08) and reported digital assets at fair value of $3,794,502, including 32.38 Bitcoin and 101,755 USDC.
Membership revenue remained the largest contributor, supplemented by Bitcoin mining and the addition of health and wellness product sales. The board authorized a $1,000,000 stock repurchase program; year‑to‑date, 8,501,503 shares were repurchased for $137,261. Preferred dividends declared year‑to‑date were $614,505.